NASDAQ
Adaptimmune Therapeutics plc (ADAP) has a market cap of $10.14M as of Thursday, December 18, 2025. The ADAP market cap is down 32.63% over the past 30 days and has declined 93.46% over the past year. Market capitalization represents the total market value of a company's outstanding shares, calculated by multiplying the stock price by the total number of shares outstanding.
No price data available for this timeframe.